Viewing StudyNCT04123795



Ignite Creation Date: 2024-05-06 @ 1:48 PM
Last Modification Date: 2024-10-26 @ 1:20 PM
Study NCT ID: NCT04123795
Status: RECRUITING
Last Update Posted: 2024-03-29
First Post: 2019-10-09

Brief Title: A Study to Evaluate the Efficacy Safety and Drug Concentration of Certolizumab Pegol CZP in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis PSO
Sponsor:
Organization: UCB Pharma